Back to ALL Research Publications
PUBLICATION_
PUBLICATION_
PUBLICATION_
PUBLICATION_
Research Category: ,
Uncovering the high prevalence of bacterial burden in surgical site wounds with point-of-care fluorescence imaging
Related Publications
Related Material
PUBLICATION_ Bacterial fluorescence imaging as a predictor of skin graft integration in burn wounds
PUBLICATION_ Integrating Point-of-Care Bacterial Fluorescence Imaging-Guided Care with Continued Wound Measurement for Enhanced Wound Area Reduction Monitoring
PUBLICATION_ The Role of Autoflorescence Imaging Device in the Evaluation of Bacteria Burden Control
PUBLICATION_ Fluorescence-Based Evaluation of Bacterial Load in Perilesional Skin: A Comparison Between Short Stretch Bandage and Zinc Oxide Bandage
MolecuLight Headquarters
425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada
US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203
T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
©2025
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.








